Stem cell hype: Join the conversation

Posted By

Michael Joyce is a multimedia producer at HealthNewsReview.org and tweets as @mlmjoyce

Ten years ago this probably wouldn’t even have been a topic of conversation.

If it had, it likely would have been about medical tourism. There would’ve been outrage directed at “third world” countries who allow unregulated and unproven stem cell “therapies” to be offered to desperate patients.

Well, that concern is now closer to home.

There are now hundreds of such clinics across the U.S. The number of clinics is growing, more people are being hurt, state and federal oversight is shockingly inadequate, and the question has become urgent: What can we do about it?

That’s precisely why we produced a recent podcast and sought out the perspectives of these people:

  • George Gibson, a patient left blind after a dubious stem cell intervention
  • Leigh Turner PhD, a bioethicist who’s been following the stem cell marketplace closely
  • Drs. Jeanne Loring and Paul Knoepfler – two PhD stem cell researchers from California 

It’s also why we’re hosting a Tweet chat about stem cells that will bring together journalists, stem cell researchers, ethicists, and hopefully many patients and family members.

The chat will be held on Wednesday, August 9 from 2 to 3 p.m. EDT under the hashtag #stemcellhype.

Questions we’ll be discussing during the chat include:

  • What is #stemcellhype? Can you share examples from news stories/PR/marketing in your area?
  • What are the harms of #stemcellhype? Why does this matter to patients and the public?
  • What advice can we give consumers trying to tell legitimate from non-legitimate stem cell therapies?
  • Stopping #stemcellhype: Where do we start? FDA? FTC? Medical boards? Journalism?

Stem cell therapies — when properly researched and applied — hold great promise. That makes it all the more critical to openly discuss stem cell interventions that are not evidence-based, not regulated, promoted in misleading ways, and have the potential to cause harm.

Please join the conversation!

You might also like

Comments

We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.

We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.

Comments are closed.